About My Health Careers Internship MedBlogs Contact us
Blood Test can Detect Antibody Mediated Kidney Rejection in Transplant Recipient

Blood Test can Detect Antibody-Mediated Kidney Rejection in Transplant Recipients

Font : A-A+

  • A non-invasive bio-marker has been developed to identify patients with antibody-mediated kidney rejection symptoms caused after transplants
  • Identification could be done through a blood test rather than a biopsy
  • The research team plans to develop it further for use in hospitals through a commercial venture.

A non-invasive biomarker to detect antibody-mediated kidney rejection symptoms in patients after transplants has been found by a group of scientists from Europe, led by KU Leuven.

Detecting Rejection after Kidney Transplants

Following a kidney transplant it is recommended that patients take medications in order to suppress their immune system. Despite this, kidney rejections occur frequently and a biopsy is usually used by doctors to determine the rejection. The rejection can be antibody-mediated or T-cell mediated. Biopsy is an uncomfortable process that involves using a needle to remove a small piece of tissue from the transplanted kidney and examining it with the help of a microscope. It also can lead to complications such as bleeding and this sometimes can lead to even graft loss. Additionally, the symptoms of rejection are very often recognized late, and effectively treating the patient is not always a possibility.


Blood Test can Detect Antibody-Mediated Kidney Rejection in Transplant Recipients

Kidney transplant patients of the University Hospitals Leuven in Belgium normally undergo a kidney biopsy three months, one year and two years after their transplant. A biopsy however, can detect rejection symptoms that are present only at that particular moment. Rejection, on the other hand could occur at any time other time too. Furthermore, the current detection methods are unable to detect around 10-20 percent of rejections that lead to graft failure which in turn would require reinitiating dialysis and another transplant.

The Study

Research in kidney transplantation has been focusing on finding biomarkers that would detect organ rejection through a blood test, for several years now. A study from Europe based out of four university hospitals in Leuven, Paris, Hannover and Limoges, headed by nephrologists from KU Leuven, has been able to find such a biomarker.

This is the first time that a biomarker for kidney transplant rejection by ANTIBODIES has been found however, biomarkers in the blood for T cell-mediated rejection is already available in practice. Unlike rejection by T cells, which is treatable, rejection with antibodies has only very few treatment options available.

"Rejection by HLA antibodies often has serious consequences," says Professor Maarten Naesens, the principal investigator of the study and a Nephrologist at the University Hospitals Leuven. "Traditional tests for assessing the function of transplanted kidneys can often only identify rejection when it is already chronic and irreversible. Thanks to our biomarker, we can detect rejection much earlier and with a simple blood test. Because the test is less invasive, we will be able to test more often than with the current biopsies," he added.

The study was divided into three phases. In the first phase, a genome-wide study was performed among 117 patients with and without kidney rejection symptoms after a transplant, to find out differences in RNA molecules. The different molecules of another group of 183 patients were processed into a mathematical model in the second phase. Eight RNA molecules that are measured with an RT-PCR technique comprise the final biomarker. The biomarker was validated in 387 patients from the four European academic hospitals in the third phase.

Using the Biomarker in the Future

Dr Elisabet Van Loon, part of the Nephrology and Kidney Transplantation research group at KU Leuven said, "In addition to developing the biomarker, that third phase was very important." She further added that, "Researchers are often satisfied with a new discovery, even though they are unable to test it in independent clinical studies. Thanks to international cooperation, we could validate our biomarker in a large group of patients. That gives us a lot of confidence in the clinical value of the new biomarker."

The next step for the research team is to hold discussions with medical diagnostic companies about further developing and standardizing the tests. Professor Naesens commented that, "In principle, our antibody rejection test has been sufficiently validated for commercialization. This is the next and necessary step to be able to offer the test to patients. With the test, patients who have no rejection of antibodies will no longer have to undergo a biopsy. The biomarker will also help to detect rejection sooner and will support the search for better medicines against rejection by antibodies."

Reference :
  1. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study - (https://doi.org/10.1016/j.ebiom.2019.07.028)

Source: Medindia

News A-Z
News Category
What's New on Medindia
Ten Fruits for Diabetics
Natural Supplements Help Reverse Hair Loss during Menopause
Ways to Manage Stress during COVID-19 Pandemic
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Glomerulonephritis Thalassemia Urinary Stones In Children Undescended Testicles Vesico-Ureteric Reflux Causing UTI in Children Hydronephrosis / Antenatal Counseling Kidney Disease Kidney Varicocele Kidney Health 

Recommended Reading
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn ......
Low Levels of Antibodies Against Donated Organs Increases Risk of Organ Rejection Among Kidney Transplant Recipients
A new study reveals that the risk of organ rejection and kidney failure is high among kidney ......
Transplant Recipients May Not Require Anti-rejection Drugs Anymore
Anti-rejection drugs are not needed for transplant recipients, as immune tolerance to transplant ......
Fluorescent Urine Test Can Detect Organ Transplant Rejection: Here’s How
Fluorescing urine indicates organ transplant rejection. Nanoparticle sensors emit fluorescent ......
Glomerulonephritis is used to describe several kidney disease that damage the glomeruli. Glomerulone...
Hydronephrosis / Antenatal Counseling
Currently most pregnant women undergo one or two ultrasound scans during their pregnancy....
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...
Undescended Testicles
An undescended testicle / testis is one that has not descended into the scrotal sac before birth. It...
Urinary Stones In Children
There is a wide misconception that only adults develop stones. On the contrary kidney stones are ver...
Vesico-Ureteric Reflux Causing UTI in Children
Bacterial infection of urinary bladder can cause pain and burning sensation while passing urine. Abn...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use